Skip to main content
Yasmine N. White
No Rating Available
(Learn About Our Rating System)

Yasmine N. White, MD, FAAP

Languages spoken: English

Clinical Locations

Primary Location

Primary Children's Hospital

Pediatric Neonatology
100 N Mario Capecchi Drive
Salt Lake City , UT 84113

University of Utah Hospital

Pediatric Neonatology
50 N Medical Dr
Salt Lake City , UT 84132

Primary Children's Hospital - Lehi

Pediatric Neonatology
2250 N Miller Campus Dr
Lehi , UT 84043

Board Certification

American Board of Pediatrics (Sub: Neonatal-Perinatal Medicine)
American Board of Pediatrics (Pediatrics)

Board Certification and Academic Information

Academic Departments Pediatrics -Assistant Professor (Clinical)
Academic Divisions Neonatology
Board Certification
American Board of Pediatrics (Sub: Neonatal-Perinatal Medicine)
American Board of Pediatrics (Pediatrics)

Education history

Undergraduate Biology & Mathematics - Bowdoin College B.A.
Professional Medical Medicine - University of Michigan Medical School M.D.
Internship General Surgery - Stanford University School of Medicine Intern
Residency Pediatrics - Boston Combined Residency Program - Boston Children's Hospital Intern/Resident
Fellowship Neonatal-Perinatal Medicine - University of California, San Francisco School of Medicine Fellow
Fellowship Clinical Pharmacology and Therapeutics - University of California, San Francisco School of Medicine Postdoctoral Research Fellow

Selected Publications

Journal Article

  1. Solans BP, Miyakawa R, Shin M, Hesseling AC, White Y, Masini T, Kanchar A, Falzon D, Savic R (2025). Deriving Dosages for Levofloxacin Tuberculosis Preventive Treatment for Young People Exposed to Rifampicin-Resistant Tuberculosis. The Journal of infectious diseases, 232(5), 1178-1186.
  2. Mike JK, White Y, Ha J, Iranmahboub A, Hawkins C, Hutchings RS, Vento C, Manzoor H, Wang A, Goudy BD, Vali P, Lakshminrusimha S, Gobburu JVS, Long-Boyle J, Fineman JR, Ferriero DM, Maltepe E (2024). Perinatal Caffeine Administration Improves Outcomes in an Ovine Model of Neonatal Hypoxia-Ischemia. Stroke, 55(11), 2705-2715.
  3. White YN, Solans BP, Denti P, van der Laan LE, Schaaf HS, Vonasek B, Malik AA, Draper HR, Hussain H, Hesseling AC, Garcia-Prats AJ, Savic RM (2024). Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis. Clin Infect Dis, 78(3), 756-764.
  4. Mike JK, White Y, Hutchings RS, Vento C, Ha J, Iranmahboub A, Manzoor H, Gunewardena A, Cheah C, Wang A, Goudy BD, Lakshminrusimha S, Long-Boyle J, Fineman JR, Ferriero DM, Maltepe E (2023). Effect of Clemastine on Neurophysiological Outcomes in an Ovine Model of Neonatal Hypoxic-Ischemic Encephalopathy. Children (Basel), 10(11).
  5. Mike JK, White Y, Hutchings RS, Vento C, Ha J, Manzoor H, Lee D, Losser C, Arellano K, Vanhatalo O, Seifert E, Gunewardena A, Wen B, Wang L, Wang A, Goudy BD, Vali P, Lakshminrusimha S, Gobburu JVS, Long-Boyle J, Wu YW, Fineman JR, Ferriero DM, Maltepe E (2023). Perinatal Azithromycin Provides Limited Neuroprotection in an Ovine Model of Neonatal Hypoxic-Ischemic Encephalopathy. Stroke, 54(11), 2864-2874.
  6. Sabir H, Maes E, Zweyer M, Schleehuber Y, Imam FB, Silverman J, White Y, Pang R, Pasca AM, Robertson NJ, Maltepe E, Bernis ME (2023). Comparing the efficacy in reducing brain injury of different neuroprotective agents following neonatal hypoxia-ischemia in newborn rats: a multi-drug randomized controlled screening trial. Sci Rep, 13(1), 9467.
  7. Mike JK, Wu KY, White Y, Pathipati P, Ndjamen B, Hutchings RS, Losser C, Vento C, Arellano K, Vanhatalo O, Ostrin S, Windsor C, Ha J, Alhassen Z, Goudy BD, Vali P, Lakshminrusimha S, Gobburu JVS, Long-Boyle J, Chen P, Wu YW, Fineman JR, Ferriero DM, Maltepe E (2022). Defining Longer-Term Outcomes in an Ovine Model of Moderate Perinatal Hypoxia-Ischemia. Dev Neurosci, 44(4-5), 277-294.
  8. Chandrasekar H, White YN, Ribeiro C, Landrigan CP, Marcus CH (2021). A Changing Landscape: Exploring Resident Perspectives on Pursuing Pediatric Hospital Medicine Fellowships. Hosp Pediatr, 11(2), 109-115.
  9. White YN, Grant PE, Soul JS, Inder T, El-Dib M (2020). Early exit from neonatal therapeutic hypothermia: A single institution experience using MRI to guide decision-making. J Neonatal Perinatal Med, 13(4), 441-447.
  10. Dedhia PH, White Y, Dillman JR, Adler J, Jarboe MD, Teitelbaum DH, Hirschl RB, Gadepalli SK (2018). Reduced paraspinous muscle area is associated with post-colectomy complications in children with ulcerative colitis. J Pediatr Surg, 53(3), 477-482.
  11. White Y, Bagchi A, Van Ziffle J, Inguva A, Bollag G, Zhang C, Carias H, Dickens D, Loh M, Shannon K, Firestone AJ (2016). KRAS insertion mutations are oncogenic and exhibit distinct functional properties. Nat Commun, 7, 10647.
  12. Shankar S, Pitchiaya S, Malik R, Kothari V, Hosono Y, Yocum AK, Gundlapalli H, White Y, Firestone A, Cao X, Dhanasekaran SM, Stuckey JA, Bollag G, Shannon K, Walter NG, Kumar-Sinha C, Chinnaiyan AM (2016). KRAS Engages AGO2 to Enhance Cellular Transformation. Cell Rep, 14(6), 1448-1461.
  13. White YN, Dedhia P, Bergeron EJ, Lin J, Chang AA, Reddy RM (2016). Resident training in a new robotic thoracic surgery program. J Surg Res, 201(1), 219-25.

Editorial

  1. White Y, Castle VP, Haig A (2013). Pediatric oncology in developing countries: challenges and solutions. J Pediatr, 162(6), 1090-1, 1091.e1.